Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.120
+0.150 (5.05%)
At close: Aug 13, 2025, 4:00 PM
3.000
-0.120 (-3.85%)
Pre-market: Aug 14, 2025, 9:23 AM EDT
Absci Revenue
Absci had revenue of $593.00K in the quarter ending June 30, 2025, a decrease of -53.31%. This brings the company's revenue in the last twelve months to $4.14M, up 27.32% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.
Revenue (ttm)
$4.14M
Revenue Growth
+27.32%
P/S Ratio
90.61
Revenue / Employee
$26,357
Employees
157
Market Cap
450.36M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ABSI News
- 1 day ago - Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 7 days ago - Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - GlobeNewsWire
- 14 days ago - Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 - GlobeNewsWire
- 20 days ago - Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 20 days ago - Absci Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 20 days ago - Absci Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Absci Appoints Biopharma Leader Mary Szela to Board of Directors - GlobeNewsWire